Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323439 · ClinicalTrials.gov registry record
Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 99
- Enrollment target
NCT01323439: Completed study, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT01323439 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323439 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 100 aneurysms.
Primary Outcome
Occlusion of aneurysm based on the Raymond classification
Interventions
- DEVICE Axium™ MicroFX™ PGLA COILS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-10 |
What the finished NCT01323439 record still lists
NCT01323439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Axium™ MicroFX™ PGLA COILS is the first listed.
NCT01323439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01323439 about?
NCT01323439 is a clinical study titled "Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study". This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 100 aneurysms.
What is the current status of trial NCT01323439?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2010-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01323439?
The interventions under investigation include: Axium™ MicroFX™ PGLA COILS (DEVICE).
Who is sponsoring clinical trial NCT01323439?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia